BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 19184661)

  • 1. Nicotine psychopharmacology: policy and regulatory.
    Henningfield JE; Zeller M
    Handb Exp Pharmacol; 2009; (192):511-34. PubMed ID: 19184661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tobacco psychopharmacology and public health policy: it takes a community.
    Henningfield JE
    Exp Clin Psychopharmacol; 2011 Aug; 19(4):249-62. PubMed ID: 21728446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine psychopharmacology research contributions to United States and global tobacco regulation: a look back and a look forward.
    Henningfield JE; Zeller M
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):286-91. PubMed ID: 16463054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward a comprehensive long term nicotine policy.
    Gray N; Henningfield JE; Benowitz NL; Connolly GN; Dresler C; Fagerstrom K; Jarvis MJ; Boyle P
    Tob Control; 2005 Jun; 14(3):161-5. PubMed ID: 15923465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global patterns of nicotine and tobacco consumption.
    Hammond SK
    Handb Exp Pharmacol; 2009; (192):3-28. PubMed ID: 19184644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Handbook of experimental pharmacology 192. Nicotine psychopharmacology. Preface.
    Henningfield JE; London ED; Pogun S
    Handb Exp Pharmacol; 2009; (192):v-viii. PubMed ID: 19301485
    [No Abstract]   [Full Text] [Related]  

  • 7. Global economic and health benefits of tobacco control: part 2.
    Wipfli H; Samet JM
    Clin Pharmacol Ther; 2009 Sep; 86(3):272-80. PubMed ID: 19536066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction.
    Kozlowski LT
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S379-86. PubMed ID: 18021913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tobacco industry manipulation of nicotine dosing.
    Wayne GF; Carpenter CM
    Handb Exp Pharmacol; 2009; (192):457-85. PubMed ID: 19184659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tobacco, nicotine and harm reduction.
    Le Houezec J; McNeill A; Britton J
    Drug Alcohol Rev; 2011 Mar; 30(2):119-23. PubMed ID: 21375611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal snuff: historical review and health related aspects.
    Sapundzhiev N; Werner JA
    J Laryngol Otol; 2003 Sep; 117(9):686-91. PubMed ID: 14561353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What should be the elements of any settlement with the tobacco industry?
    Burns D; Benowitz N; N'Connolly GN; Cummings KM; Davis RM; Henningfield JE; Shopland DR; Warner KE
    Tob Control; 1997; 6(1):1-4. PubMed ID: 9176975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the cannabinoid system in nicotine addiction.
    Castañé A; Berrendero F; Maldonado R
    Pharmacol Biochem Behav; 2005 Jun; 81(2):381-6. PubMed ID: 15925402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achieving the Framework Convention on Tobacco Control's potential by investing in national capacity.
    Wipfli H; Stillman F; Tamplin S; da Costa e Silva VL; Yach D; Samet J
    Tob Control; 2004 Dec; 13(4):433-7. PubMed ID: 15564631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Policy options to reduce tobacco-caused mortality.
    Sweanor DT
    J Addict Dis; 1999; 18(3):1-11. PubMed ID: 10507577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine analogues: a review of tobacco industry research interests.
    Vagg R; Chapman S
    Addiction; 2005 May; 100(5):701-12. PubMed ID: 15847628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current trends in international tobacco control.
    Thompson F; Fagerström K
    Clin Occup Environ Med; 2006; 5(1):101-16, ix. PubMed ID: 16446257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons from the history of tobacco harm reduction: The National Cancer Institute's Smoking and Health Program and the "less hazardous cigarette".
    Parascandola M
    Nicotine Tob Res; 2005 Oct; 7(5):779-89. PubMed ID: 16191749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global economic and health benefits of tobacco control: part 1.
    Wipfli H; Samet JM
    Clin Pharmacol Ther; 2009 Sep; 86(3):263-71. PubMed ID: 19536067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tobacco epidemic in the United States.
    Giovino GA
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S318-26. PubMed ID: 18021906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.